M G Bourassa

Summary

Country: Canada

Publications

  1. ncbi Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (B
    M G Bourassa
    Department of Medicine, Montreal Heart Institute, Canada
    J Am Coll Cardiol 33:1627-36. 1999
  2. ncbi Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies
    Martial G Bourassa
    Department of Medicine and Research Center, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8
    J Am Coll Cardiol 41:351-9. 2003
  3. ncbi Clinical trials of coronary revascularization: coronary angioplasty vs. coronary bypass grafting
    M G Bourassa
    Research Center, Montreal Heart Institute, Quebec, Canada
    Curr Opin Cardiol 15:281-6. 2000
  4. ncbi Gender, depression, and one-year prognosis after myocardial infarction
    N Frasure-Smith
    Research Center, Montreal Heart Institute, Quebec, Canada
    Psychosom Med 61:26-37. 1999
  5. ncbi Biocompatibility aspects of new stent technology
    O F Bertrand
    Research Center, Montreal Heart Institute, Division of Experimental Medicine, McGill University, Quebec, Canada
    J Am Coll Cardiol 32:562-71. 1998
  6. ncbi Effect of prior revascularization on outcome following percutaneous coronary intervention; NHLBI Dynamic Registry
    M G Bourassa
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada
    Eur Heart J 23:1546-55. 2002
  7. doi Effects of fasting and/or postprandial glucose on heart rate recovery in patients with coronary heart disease
    M Gayda
    Montreal Heart Institute, Cardiovascular Prevention and Rehabilitation Center Centre ÉPIC, Universite de Montreal, Montreal, Quebec, H1T1C8, Canada
    Diabetes Metab 38:20-6. 2012
  8. ncbi Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion
    O F Bertrand
    Interventional Cardiology Laboratories, Montreal Heart Institute, Quebec, Canada
    Can J Cardiol 16:83-5. 2000
  9. ncbi Depression and health-care costs during the first year following myocardial infarction
    N Frasure-Smith
    Departments of Psychiatry, McGill University, Montreal, Quebec, Canada
    J Psychosom Res 48:471-8. 2000
  10. ncbi Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation
    Kevin E Kip
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Circulation 105:1914-20. 2002

Detail Information

Publications36

  1. ncbi Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (B
    M G Bourassa
    Department of Medicine, Montreal Heart Institute, Canada
    J Am Coll Cardiol 33:1627-36. 1999
    ..Our objective was to determine whether a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization (IR) compromises long-term patient outcome...
  2. ncbi Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies
    Martial G Bourassa
    Department of Medicine and Research Center, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8
    J Am Coll Cardiol 41:351-9. 2003
    ..Successful medical, interventional, or surgical therapy leads not only to marked improvement or normalization of these alterations but also relief of angina and ischemia...
  3. ncbi Clinical trials of coronary revascularization: coronary angioplasty vs. coronary bypass grafting
    M G Bourassa
    Research Center, Montreal Heart Institute, Quebec, Canada
    Curr Opin Cardiol 15:281-6. 2000
    ..In patients with single vessel disease, these long-term data suggest that bypass surgery is at least as safe and effective as coronary angioplasty and therefore may be a treatment option in selected cases...
  4. ncbi Gender, depression, and one-year prognosis after myocardial infarction
    N Frasure-Smith
    Research Center, Montreal Heart Institute, Quebec, Canada
    Psychosom Med 61:26-37. 1999
    ..The purpose of this study was to assess gender differences in the impact of depression on 1-year cardiac mortality in patients hospitalized for an acute myocardial infarction (MI)...
  5. ncbi Biocompatibility aspects of new stent technology
    O F Bertrand
    Research Center, Montreal Heart Institute, Division of Experimental Medicine, McGill University, Quebec, Canada
    J Am Coll Cardiol 32:562-71. 1998
    ..The combined efforts of basic scientists and clinicians will undoubtedly contribute to the improvement of stent biocompatibility in the future...
  6. ncbi Effect of prior revascularization on outcome following percutaneous coronary intervention; NHLBI Dynamic Registry
    M G Bourassa
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada
    Eur Heart J 23:1546-55. 2002
    ..Their outcome after PCI has seldom been compared to that of patients without prior procedures. This study investigates which elements of prior revascularization affect in-hospital and long-term outcome after PCI...
  7. doi Effects of fasting and/or postprandial glucose on heart rate recovery in patients with coronary heart disease
    M Gayda
    Montreal Heart Institute, Cardiovascular Prevention and Rehabilitation Center Centre ÉPIC, Universite de Montreal, Montreal, Quebec, H1T1C8, Canada
    Diabetes Metab 38:20-6. 2012
    ..For this reason, we sought to determine the relationships between HRR and both fasting and postprandial glycaemia...
  8. ncbi Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion
    O F Bertrand
    Interventional Cardiology Laboratories, Montreal Heart Institute, Quebec, Canada
    Can J Cardiol 16:83-5. 2000
    ..He was then managed by abciximab therapy alone. Control angiography showed complete resolution of the thrombotic occlusions. His subsequent clinical course was uneventful...
  9. ncbi Depression and health-care costs during the first year following myocardial infarction
    N Frasure-Smith
    Departments of Psychiatry, McGill University, Montreal, Quebec, Canada
    J Psychosom Res 48:471-8. 2000
    ..This study uses Quebec Medicare data to examine the relationship between post-MI depression and physician costs, including both out-patient care and hospital readmissions...
  10. ncbi Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation
    Kevin E Kip
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Circulation 105:1914-20. 2002
    ..Importantly, diabetes mellitus may differentially influence long-term survival after PTCA or CABG...
  11. ncbi Angiotensin II inhibition and prevention of atrial fibrillation and stroke
    Martial G Bourassa
    J Am Coll Cardiol 45:720-1. 2005
  12. ncbi Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
    Ariel Diaz
    Department of Medicine, Research Center, Montreal Heart Institute, 5000 Belanger Street E, H1T 1C8 Montreal, Canada
    Eur Heart J 26:967-74. 2005
    ..Heart rate reduction is the cornerstone of the treatment of angina. The purpose of this study was to explore the prognostic value of heart rate in patients with stable coronary artery disease (CAD)...
  13. ncbi The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease
    Anil Nigam
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Am Heart J 151:514-21. 2006
    ..We sought to assess the impact of the metabolic syndrome and its individual components on intermediate-term and long-term outcomes in patients with CHD...
  14. ncbi Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Am Heart J 152:705-12. 2006
    ..Limited data are available to predict the occurrence of hyperkalemia. Risk assessment is complicated by the lack of consistency of definition between trials...
  15. ncbi Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management
    Colin Berry
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Am Coll Cardiol 49:631-42. 2007
    ..Noncompliance, particularly with lifestyle measures, and underprescription of evidence-based therapies remain important unsolved problems...
  16. ncbi Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization
    Colin Berry
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Am Coll Cardiol 49:643-56. 2007
    ..Improvements in PCI and coronary artery bypass graft surgery are leading to better results in diabetic patients, and clinical trials are presently comparing contemporary PCI with surgery...
  17. pmc Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease
    Anil Nigam
    Montreal Heart Institute, Universite de Montreal, Montreal, Canada
    Can J Cardiol 23:873-8. 2007
    ..Postprandial glycemia may be a stronger CAD risk factor than fasting glycemia in patients without documented heart disease...
  18. pmc Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Can J Cardiol 24:45-8. 2008
    ..Currently, the relationship between temporal variations in hematocrit and specific causes of mortality and morbidity, as well as the most appropriate way to monitor changes in hematocrit, is unknown...
  19. ncbi Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes
    Martial G Bourassa
    Department of Medicine, Montreal Heart Institute, Universite de Montreal, 5000 Belanger Street, Montreal, QC, Canada H1T 1C8
    Curr Atheroscler Rep 10:106-16. 2008
    ..Noncompliance with medications and/or lifestyle measures and underprescription of evidence-based therapies remain important unsolved problems...
  20. doi Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease
    Francisco Javier Apullan
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 102:375-9. 2008
    ..49, p = 0.03 for all-cause mortality; adjusted HR 1.25, 95% CI 0.99 to 1.57, p = 0.05 for CV mortality). In conclusion, leisure-time physical activity independently predicted long-term survival in men and women with chronic stable CHD...
  21. ncbi Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination
    B Charles Solymoss
    Research Center, Montreal Heart Institute, Montreal, QC, Canada
    Clin Biochem 37:286-92. 2004
    ..To study the usefulness of combined cardiac Troponin T (cTnT) and CK-MB mass determinations in risk stratification of acute coronary syndromes...
  22. ncbi Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI)
    Edwin L Alderman
    Cardiovascular Division, Stanford University, Stanford, California, USA
    J Am Coll Cardiol 44:766-74. 2004
    ..Coronary angiograms obtained five years following revascularization were examined to assess the extent of compromise in myocardial perfusion due to failure of revascularization versus progression of native disease...
  23. ncbi Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal heart attack readjustment trial
    Nancy Frasure-Smith
    Department of Psychiatry, McGill University, Research Center, Montreal Heart Institute, QC, Canada
    Psychosom Med 64:571-9. 2002
    ..The potential mediating roles of medications, medical care utilization, and changes in negative emotions over the program are also explored...
  24. ncbi Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction
    Francois Lesperance
    Department of Psychiatry, University of Montreal and McGill University, Canada
    Circulation 105:1049-53. 2002
    ..Although previous research demonstrated an independent link between depression symptoms and cardiac mortality after myocardial infarction (MI), depression was assessed only once, and a dose-response relationship was not evaluated...
  25. ncbi Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry
    Richard Holubkov
    Department of Epidemiology, Cardiovascular Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Am Heart J 144:826-33. 2002
    ..As percutaneous coronary intervention (PCI) is most commonly performed for relief of angina, it is important to identify factors associated with recurrence of anginal symptoms...
  26. ncbi Effects of AGI-1067 and probucol after percutaneous coronary interventions
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Canada
    Circulation 107:552-8. 2003
    ..In a multicenter trial, we studied whether AGI-1067 reduces restenosis assessed by intravascular ultrasound (IVUS) after percutaneous coronary intervention (PCI) compared with placebo and probucol used as a positive control...
  27. ncbi Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease
    Bela C Solymoss
    Research Center, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec H1T 1C8, Canada
    Coron Artery Dis 14:207-12. 2003
    ....
  28. ncbi Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials
    Emmanuelle Vermes
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Circulation 107:2926-31. 2003
    ....
  29. ncbi Incidence, coronary risk profile and angiographic characteristics of prediabetic and diabetic patients in a population with ischemic heart disease
    B Charles Solymoss
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Can J Cardiol 19:1155-60. 2003
    ..00 mmol/L (126 mg/dL) and the term 'impaired fasting glucose' (IFG; fasting blood glucose ranging from 6.11 mmol/L to 6.99 mmol/L or from 110 mg/dL to 126 mg/dL) was introduced to define a prediabetic state...
  30. ncbi Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity
    B Charles Solymoss
    Montreal Heart Institute, McGill University Health Centre, Montreal, Quebec, Canada
    Am J Cardiol 93:159-64. 2004
    ..Therefore, the MS score provides a clinically useful index of MS severity and the associated atherosclerotic risk factor profile. It also correlates with the angiographic severity of CAD and its clinical complications...
  31. ncbi Classification and risk stratification of patients with acute chest pain using a low discriminatory level of cardiac troponin T
    B Charles Solymoss
    Department of Laboratory Medicine, Montreal Heart Institute, Montreal, Quebec, Canada
    Clin Cardiol 27:130-6. 2004
    ..20 or 0.10 microg/l cardiac troponin T (cTnT) levels. With the highly sensitive and specific second- and third-generation assays, cTnT is undetectable in most healthy individuals...
  32. ncbi Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    J Card Fail 12:353-9. 2006
    ..The role of temporal changes of more conventional markers of inflammation, such as the white blood cell (WBC) count, on clinical outcomes remains largely unknown...
  33. ncbi Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD)
    Emmanuelle Vermes
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Circulation 107:1291-6. 2003
    ....
  34. ncbi The history of cardiac catheterization
    Martial G Bourassa
    Montreal Heart Institute, Quebec
    Can J Cardiol 21:1011-4. 2005
    ..On the occasion of the 50th anniversary of the Montreal Heart Institute, it seems appropriate to highlight the contribution of this institution in these two areas...
  35. ncbi Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina
    Jean Claude Tardif
    Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada
    Eur Heart J 26:2529-36. 2005
    ..Ivabradine has shown anti-ischaemic and anti-anginal activity in a placebo-controlled trial. The objective of this study was to compare the anti-anginal and anti-ischaemic effects of ivabradine and the beta-blocker atenolol...
  36. ncbi Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial
    Philip A Poole-Wilson
    Cardiac Medicine, Imperial College London, Dovehouse Street, London SW3 6LY, UK
    Lancet 364:849-57. 2004
    ..We aimed to investigate the effect of the calcium antagonist nifedipine on long-term outcome in patients with stable angina pectoris...